Last reviewed · How we verify
Pollutox (OZONE)
At a glance
| Generic name | OZONE |
|---|---|
| Sponsor | Deseret Biologicals, Inc. |
| Drug class | Radiographic Contrast Agent [EPC] |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- nausea
- fatigue
- head discomfort
- abdominal discomfort
Common side effects
Key clinical trials
- Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome (NA)
- Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis (NA)
- Ozone Reaction Products and Skin Health (NA)
- Comparison of ESWT and Ultrasound-Guided Ozone Injection in Lateral Epicondylitis (NA)
- Effect of Topical Ozone on The Healing Diabetic Foot Ulcer (NA)
- Ozone Injection vs ESWT for Chronic Achilles Tendinopathy (NA)
- Postoperative Ozonated Oil Dressing After Open Inguinal Hernia Repair: A Randomized Pilot Trial (NA)
- Ozone Application in Periodontal Treatment (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pollutox CI brief — competitive landscape report
- Pollutox updates RSS · CI watch RSS
- Deseret Biologicals, Inc. portfolio CI